iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 1,641 shares, a decrease of 63.7% from the December 31st total of 4,523 shares. Approximately 1.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,499 shares, the days-to-cover ratio is currently 1.1 days. Based on an average daily trading volume, of 1,499 shares, the days-to-cover ratio is currently 1.1 days. Approximately 1.1% of the shares of the stock are short sold.

iShares Neuroscience and Healthcare ETF Trading Up 0.8%

Shares of NYSEARCA IBRN traded up $0.27 during trading on Thursday, reaching $33.02. The company had a trading volume of 196 shares, compared to its average volume of 3,726. iShares Neuroscience and Healthcare ETF has a twelve month low of $17.86 and a twelve month high of $37.00. The stock has a 50-day moving average price of $32.10 and a two-hundred day moving average price of $28.26. The stock has a market capitalization of $4.95 million, a PE ratio of 15.61 and a beta of 0.93.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.